BackgroundUnder the Global Programme to Eliminate Lymphatic Filariasis (LF), American Samoa conducted mass drug administration (MDA) from 2000-2006. Despite passing Transmission Assessment Surveys (TAS) in 2011/2012 and 2015, American Samoa failed TAS-3 in 2016, with antigen (Ag) prevalence of 0.7% (95%CI 0.3-1.8%) in 6-7year-olds. A 2016 community survey (Ag prevalence 6.2% (95%CI 4.4-8.5%) in age 8 years) confirmed resurgence. Here, we explore the potential of targeted strategies to strengthen post-MDA surveillance.
Methodology/Principal FindingsUsing Ag data plus new antibody data (Wb123, Bm14, Bm33) from the 2016 surveys, we identified risk factors for seropositivity using multivariable logistic regression. We compared TAS with strategies that targeted highrisk subpopulations (older ages, householders of Ag-positive TAS children [index children]) and/or known hotspots, and used NNTest av (average number needed to test to identify one positive) to compare sampling efficiency.Antibody prevalence in TAS-3 (n=1143) were 1.6% for Bm14 (95%CI 0.9-2.9%), 7.9% for Wb123 (95%CI 6.4-9.6%), and 20.2% for Bm33 (95%CI 16.7-24.3%); and in the community survey (n=2507), 13.9% for Bm14 (95%CI 11.2-17.2%), 27.9% for Wb123 (95%CI 24.6-31.4%), and 47.3% for Bm33 (95%CI 42.1-52.6%). Ag prevalence was 20.7% (95%CI 9.7-53.5%) in households of index children. Higher Ag prevalence was found in males (adjusted odds ratio [aOR] 3.01), age 18 years (aOR 2.18), residents of Fagali'i (aOR 15.81), and outdoor workers (aOR 2.61). Using Ag, NNTest av ranged from 142.5 for TAS, to <5 for households of index children.NNTest av was lower in older ages, and highest for Ag, followed by Bm14, Wb123 and Bm33 antibodies.
Conclusions/SignificanceAll rights reserved. No reuse allowed without permission.